Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 31;6(5):e32740.
doi: 10.2196/32740.

Pilot Testing in the Wild: Feasibility, Acceptability, Usage Patterns, and Efficacy of an Integrated Web and Smartphone Platform for Bipolar II Disorder

Affiliations

Pilot Testing in the Wild: Feasibility, Acceptability, Usage Patterns, and Efficacy of an Integrated Web and Smartphone Platform for Bipolar II Disorder

Kathryn Fletcher et al. JMIR Form Res. .

Abstract

Background: Bipolar II disorder (BD-II) is associated with significant burden, disability, and mortality; however, there continues to be a dearth of evidence-based psychological interventions for this condition. Technology-mediated interventions incorporating self-management have untapped potential to help meet this need as an adjunct to usual clinical care.

Objective: The objective of this pilot study is to assess the feasibility, acceptability, and clinical utility of a novel intervention for BD-II (Tailored Recovery-oriented Intervention for Bipolar II Experiences; TRIBE), in which mindfulness-based psychological content is delivered via an integrated web and smartphone platform. The focus of the study is evaluation of the dynamic use patterns emerging from ecological momentary assessment and intervention to assist the real-world application of mindfulness skills learned from web-delivered modules.

Methods: An open trial design using pretest and posttest assessments with nested qualitative evaluation was used. Individuals (aged 18-65 years) with a diagnosis of BD-II were recruited worldwide and invited to use a prototype of the TRIBE intervention over a 3-week period. Data were collected via web-based questionnaires and phone interviews at baseline and 3-week follow-up.

Results: A total of 25 participants completed baseline and follow-up assessments. Adherence rates (daily app use) were 65.6% across the 3-week study, with up to 88% (22/25) of participants using the app synergistically alongside the web-based program. Despite technical challenges with the prototype intervention (from user, hardware, and software standpoints), acceptability was adequate, and most participants rated the intervention positively in terms of concept (companion app with website: 19/25, 76%), content (19/25, 76%), and credibility and utility in supporting their management of bipolar disorder (17/25, 68%). Evaluation using behavioral archetypes identified important use pathways and a provisional model to inform platform refinement. As hypothesized, depression scores significantly decreased after the intervention (Montgomery-Asberg Depression Rating Scale baseline mean 8.60, SD 6.86, vs follow-up mean 6.16, SD 5.11; t24=2.63; P=.01; Cohen d=0.53, 95% CI 0.52-4.36).

Conclusions: Our findings suggest that TRIBE is feasible and represents an appropriate and acceptable self-management program for patients with BD-II. Preliminary efficacy results are promising and support full development of TRIBE informed by the present behavioral archetype analysis. Modifications suggested by the pilot study include increasing the duration of the intervention and increasing technical support.

Keywords: app; bipolar disorder; ecological momentary assessment; mobile phone; smartphone; web-based intervention.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Content of the web-based program. TRIBE: Tailored Recovery-oriented Intervention for Bipolar II Experiences.
Figure 2
Figure 2
Tailored Recovery-oriented Intervention for Bipolar II Experiences ideal user flow journey.
Figure 3
Figure 3
Summary of observed frequency of steps in ideal user flow journey.
Figure 4
Figure 4
Illustrative use pathways.
Figure 5
Figure 5
Participant engagement with Targeted Recovery-Oriented Intervention for Bipolar II Experiences.

Similar articles

Cited by

References

    1. Merikangas KR, Jin R, He J, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011 Mar;68(3):241–51. doi: 10.1001/archgenpsychiatry.2011.12. http://europepmc.org/abstract/MED/21383262 68/3/241 - DOI - PMC - PubMed
    1. Maina G, Albert U, Bellodi L, Colombo C, Faravelli C, Monteleone P, Bogetto F, Cassano GB, Maj M. Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Clin Psychiatry. 2007 Feb;68(2):207–12. doi: 10.4088/jcp.v68n0205. - DOI - PubMed
    1. Plans L, Barrot C, Nieto E, Rios J, Schulze T, Papiol S, Mitjans M, Vieta E, Benabarre A. Association between completed suicide and bipolar disorder: a systematic review of the literature. J Affect Disord. 2019 Jan 01;242:111–22. doi: 10.1016/j.jad.2018.08.054.S0165-0327(18)30514-7 - DOI - PubMed
    1. Baek JH, Park DY, Choi J, Kim JS, Choi JS, Ha K, Kwon JS, Lee D, Hong KS. Differences between bipolar I and bipolar II disorders in clinical features, comorbidity, and family history. J Affect Disord. 2011 Jun;131(1-3):59–67. doi: 10.1016/j.jad.2010.11.020.S0165-0327(10)00717-2 - DOI - PubMed
    1. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Maser J, Rice JA, Solomon DA, Keller MB. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord. 2003 Jan;73(1-2):19–32. doi: 10.1016/s0165-0327(02)00324-5.S0165032702003245 - DOI - PubMed